Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Phase I CARLYSLE study: CAR T-cell therapy obe-cel shows favorable safety and clinical benefit in severe refractory lupus

This article reports initial results from the phase I CARLYSLE study evaluating obecabtagene autoleucel (obe-cel), a CD19-targeting CAR T-ce

GSK and Xenoport resubmit new drug application for Solzira™ in restless legs syndrome

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells